Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$918,763
+$285,042 QoQ
Shares Held
766
+11.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#3,217
of 4,605 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BridgePort Financial Solutions, LLC holds $10,049,479 across 11 Drug Manufacturers - General names. LLY ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
128,811 | $3,101,768 | |
| 2 | JNJ |
Johnson & Johnson
|
5,466 | $1,388,200 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,290 | $1,193,765 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
766 | $918,763 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,943 | $861,015 | |
| 6 | AMGN |
Amgen Inc
|
2,213 | $801,371 | |
| 7 | GSK |
GSK plc
|
8,090 | $424,077 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,081 | $389,253 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $918,763 | 766 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $633,721 | 689 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $711,438 | 662 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $526,470 | 690 | Shares | Sole | 2025-11-06 | |
| 2024-12-31 | $179,876 | 233 | Shares | Sole | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||